Cargando…

Diagnostic and prognostic values of AKR1C3 and AKR1D1 in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is the most common histological type of primary liver cancer and the majority of patients are diagnosed at an advanced stage and have a poor prognosis. AKR1C3 (Aldo-keto reductase family 1 member C3) and AKR1D1 (Aldo-keto reductase family 1 member D1) catalyze the conv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Pengfei, Feng, Ruo, Lu, Xu, Liao, Yuan, Du, Zhicheng, Zhai, Wenlong, Chen, Kunlun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906155/ https://www.ncbi.nlm.nih.gov/pubmed/33493134 http://dx.doi.org/10.18632/aging.202380

Ejemplares similares

Diagnostic and Prognostic Potential of AKR1B10 in Human Hepatocellular Carcinoma
por: DiStefano, Johanna K., et al.
Publicado: (2019)

AKR1B1 and AKR1B10 as Prognostic Biomarkers of Endometrioid Endometrial Carcinomas
por: Hojnik, Marko, et al.
Publicado: (2021)

Enzymes of the AKR1B and AKR1C Subfamilies and Uterine Diseases
por: Rižner, Tea Lanišnik
Publicado: (2012)

Expression of the Aldo-Ketoreductases AKR1B1 and AKR1B10 in Human Cancers
por: Laffin, Brian, et al.
Publicado: (2012)

AKR1C1 overexpression leads to lenvatinib resistance in hepatocellular carcinoma
por: Gao, Cheng, et al.
Publicado: (2023)

AKR1B10 in gastrointestinal diseases
por: Shen, Yi, et al.
Publicado: (2015)

Clinical value of AKR1B10 in hepatocellular carcinoma: A systematic review and meta-analysis
por: Wang, Zixiang, et al.
Publicado: (2022)

Expression of progesterone metabolizing enzyme genes (AKR1C1, AKR1C2, AKR1C3, SRD5A1, SRD5A2) is altered in human breast carcinoma
por: Lewis, Michael J, et al.
Publicado: (2004)

Roles of AKR1C3 in malignancy
por: Xiao, Xin-Zhu, et al.
Publicado: (2021)

Aldo–Keto Reductase AKR1C1–AKR1C4: Functions, Regulation, and Intervention for Anti-cancer Therapy
por: Zeng, Chen-Ming, et al.
Publicado: (2017)

In-silico Investigations of quinine and quinidine as potential Inhibitors of AKR1B1 and AKR1B10: Functional and structural characterization
por: Ejaz, Syeda Abida, et al.
Publicado: (2022)

Ruthenium complexes show potent inhibition of AKR1C1, AKR1C2, and AKR1C3 enzymes and anti-proliferative action against chemoresistant ovarian cancer cell line
por: Kljun, Jakob, et al.
Publicado: (2022)

The roles of AKR1C1 and AKR1C2 in ethyl-3,4-dihydroxybenzoate induced esophageal squamous cell carcinoma cell death
por: Li, Wei, et al.
Publicado: (2016)

Modeling Single Nucleotide Polymorphisms in the Human AKR1C1 and AKR1C2 Genes: Implications for Functional and Genotyping Analyses
por: Arthur, Jonathan W., et al.
Publicado: (2010)

AKR1C2 and AKR1C3 expression in adipose tissue: Association with body fat distribution and regulatory variants
por: Ostinelli, Giada, et al.
Publicado: (2021)

Regulation Network and Prognostic Significance of Aldo-Keto Reductase (AKR) Superfamily Genes in Hepatocellular Carcinoma
por: Dai, Tianxing, et al.
Publicado: (2021)

Pleiotropic Actions of Aldehyde Reductase (AKR1A)
por: Fujii, Junichi, et al.
Publicado: (2021)

The Role of AKR1B10 in Physiology and Pathophysiology
por: Endo, Satoshi, et al.
Publicado: (2021)

AKR1C1-3, notably AKR1C3, are distinct biomarkers for liver cancer diagnosis and prognosis: Database mining in malignancies
por: Zhao, Shou-Feng, et al.
Publicado: (2019)

Selective AKR1C3 inhibitors do not recapitulate the anti-leukaemic activities of the pan-AKR1C inhibitor medroxyprogesterone acetate
por: Khanim, F, et al.
Publicado: (2014)

Prognostic significance of AKR1B10 in patients with resected lung adenocarcinoma
por: Hung, Jung‐Jyh, et al.
Publicado: (2018)

Transcriptomic Profiling Reveals AKR1C1 and AKR1C3 Mediate Cisplatin Resistance in Signet Ring Cell Gastric Carcinoma via Autophagic Cell Death
por: Phoo, Nang Lae Lae, et al.
Publicado: (2021)

Glucocorticoids regulate AKR1D1 activity in human liver in vitro and in vivo
por: Nikolaou, Nikolaos, et al.
Publicado: (2020)

Fidarestat induces glycolysis of NK cells through decreasing AKR1B10 expression to inhibit hepatocellular carcinoma
por: Wu, Tiangen, et al.
Publicado: (2021)

AKR1B1 as a Prognostic Biomarker of High-Grade Serous Ovarian Cancer
por: Hojnik, Marko, et al.
Publicado: (2022)

AKR1C3 Is Associated with Better Survival of Patients with Endometrial Carcinomas
por: Hojnik, Marko, et al.
Publicado: (2020)

The expression and significance of AKR1B10 in laryngeal squamous cell carcinoma
por: Liu, Jixuan, et al.
Publicado: (2021)

Haemopoietic stem cells in leukaemic AKR mice: the (AKR x C57BL/6)F1 mouse as an in vivo assay system.
por: Schwartz, G. N., et al.
Publicado: (1982)

Knockdown of AKR1C3 Promoted Sorafenib Sensitivity Through Inhibiting the Phosphorylation of AKT in Hepatocellular Carcinoma
por: Zheng, Jia, et al.
Publicado: (2022)

AKR1D1 knockout mice develop a sex-dependent metabolic phenotype
por: Gathercole, Laura L, et al.
Publicado: (2022)

Genetic study of lymphoma induction by AKR mink cell focus-inducing virus in AKR x NFS crosses
Publicado: (1981)

Up-Regulated AKR1C2 is correlated with favorable prognosis in thyroid carcinoma
por: Jin, Yi-Xiang, et al.
Publicado: (2019)

AKR1C enzymes sustain therapy resistance in paediatric T-ALL
por: Bortolozzi, Roberta, et al.
Publicado: (2018)

Analogues of Natural Chalcones as Efficient Inhibitors of AKR1C3
por: Möller, Gabriele, et al.
Publicado: (2022)

AKR1C3-dependent lipid droplet formation confers hepatocellular carcinoma cell adaptability to targeted therapy
por: Wu, Changqing, et al.
Publicado: (2022)

Avasimibe Dampens Cholangiocarcinoma Progression by Inhibiting FoxM1-AKR1C1 Signaling
por: Gao, Yunshu, et al.
Publicado: (2021)

Differential activity and expression of human 5β-reductase (AKR1D1) splice variants
por: Appanna, Nathan, et al.
Publicado: (2021)

An Apoptotic Gene Signature for the Prognosis of Hepatocellular Carcinoma
por: Chen, Kunlun, et al.
Publicado: (2021)

Long read sequencing characterises a novel structural variant, revealing underactive AKR1C1 with overactive AKR1C2 as a possible cause of severe chronic fatigue
por: Oakley, Julia, et al.
Publicado: (2023)

Pretreatment AKR1B10 expression predicts the risk of hepatocellular carcinoma development after hepatitis C virus eradication
por: Murata, Ayato, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_rtdcc4h8e85joug6ncouhnk040